1. Cholestatic drugs impair bile acid profiles and disposition in HepaRG cells. (16th September 2016) Authors: Sharanek, A.; Burban, A.; Humbert, L.; Rainteau, D.; Guillouzo, A. Journal: Toxicology letters Issue: Volume 258(2016)Supplement Page Start: S55 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Dose-dependent intracellular accumulation of endogenous bile acids in cyclosporine A-treated HepaRG hepatocytes. (16th October 2015) Authors: Sharanek, A.; Burban, A.; Humber, L.; Bachour-El Azzi, P.; Felix-Gomes, N.; Rainteau, D.; Guillouzo, A. Journal: Toxicology letters Issue: Volume 238(2015)Supplement Page Start: S301 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Evaluation of cholestatic potential of endothelin receptor antagonists. (16th September 2016) Authors: Burbank, M.G.; Sharanek, A.; Burban, A.; Mialanne, H.; Aerts, H.; Guguen Guillouzo, C.; Weaver, R.J.; Guillouzo, A. Journal: Toxicology letters Issue: Volume 258(2016)Supplement Page Start: S135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. New insights in mechanisms involved in flucloxacillin-induced intra-hepatic cholestasis using human HepaRG and primary hepatocytes. (16th September 2016) Authors: Burban, A.; Sharanek, A.; Guillouzo, C. Guguen; Guillouzo, A. Journal: Toxicology letters Issue: Volume 258(2016)Supplement Page Start: S235 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Selective bile canalicular changes induced by cholestatic drugs. (16th October 2015) Authors: Burbank, M.; Sharanek, A.; Burban, A.; Weaver, R.J.; Guguen-Guillouzo, C.; Guillouzo, A. Journal: Toxicology letters Issue: Volume 238(2015)Supplement Page Start: S301 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗